I think you are right. Very few things in life sell themselves and to think that a small biotech can compete with a multinational pharmaceutical company on the sales side is silly. Irrespective of what price I eventually sell the bulk of my ARIAD holdings I do think I will look to exit at some point after Pona results are in, 113 results are in but before we starting selling Pona. I mean once you start selling the product all the good news is baked in and the only surprise is normally bad.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.